Last reviewed · How we verify
NCT04909281
Feasibility of Sending a Direct Send HPV Self-sampling Kit to Long-term Screening Non-attenders
trial testing Self-sampling HPV in HPV in 741 participants. Completed in 4 April 2020.
3 September 2019
Quick facts
| Lead sponsor | Falu Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 741 |
| Start date | 28 August 2019 |
| Primary completion | 3 September 2019 |
| Estimated completion | 4 April 2020 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Self-sampling HPV
Conditions studied
- HPV — all drugs for HPV →
- Cervical Cancer — all drugs for Cervical Cancer →
Sponsor
Falu Hospital
Who can join
Adults 33 to 70, female only, with HPV or Cervical Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All women in one Swedish county who had not participated in the organized screening program for at least 10 years were sent an HPV self-sampling kit. Women who were positive for HPV were referred to a gynecological examination including colposcopy and further testing according to national guidelines.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04909281
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HPV
Currently open trials in the same condition.
- NCT07493928 — HPV After chemoRadioTherapy · recruiting
- NCT07065630 — Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer · Phase 2 · recruiting
- NCT06796738 — Advancing Cervical Cancer Screening Through the Emergency Department - IIS · NA · active not recruiting
- NCT07273383 — Self-sampling for HPV Screening · NA · active not recruiting
- NCT07438080 — Concordance and Acceptability of Self-screening Compared to Screening Carried Out by a Health Professional for HPV, a Ri · NA · recruiting
Other Falu Hospital trials
Trials by the same sponsor.
- NCT04909814 — Colposcopic Impression in a Birth Cohort Previously Eligible for HPV-vaccination · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04909281 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Falu Hospital
- Last refreshed: 1 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04909281.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing